Lv3
270 积分 2026-03-12 加入
Immunotyping in tubo‐ovarian high‐grade serous carcinoma by PD‐L1 and CD8+ T‐lymphocytes predicts disease‐free survival
2个月前
已完结
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor
2个月前
已完结
Terminal T-cell exhaustion predicts tumor control independent of immunotherapy in ovarian cancer
2个月前
已完结
Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score
2个月前
已完结
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
2个月前
已完结
BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality
2个月前
已完结
Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches
2个月前
已完结
Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)
3个月前
已完结
Epithelial ovarian cancer
3个月前
已完结
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
3个月前
已完结
皖公网安备34019202002308
